Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for GRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -1.379M
March 31, 2026 -2.117M
December 31, 2025 -1.109M
September 30, 2025 -1.923M
June 30, 2025 -3.208M
March 31, 2025 -2.801M
Date Value
December 31, 2024 -48.27M
September 30, 2024 44.93M
June 30, 2024 -14.39M
March 31, 2024 -5.912M
December 31, 2023 -13.28M
September 30, 2023 -10.15M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Medical Care Technologies, Inc. -0.1044M
Cosmos Health, Inc. 1.863M
Organogenesis Holdings, Inc. -12.50M
cbdMD, Inc. -0.0597M
Agape ATP Corp. -0.0824M